SEC-sourced researchBeta
RAJAF
TFA Therapeutics, Inc.
Company comparison ↗
Data passport
- CIK
- 0001885680
- Exchange
- OTC
- Business activity
- — · SIC 2833
- Financial inputs
- 6/6
- Filing date
- Sep 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 882,533.0000 | May 15, 2026 |
| December 2024 | 1,253,484.0000 | May 15, 2026 |
| December 2025 | 1,245,348.0000 | May 15, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,245,348.0000 | -154,822.0000 | -35,845.0000 | 4,657,511.0000 | 5,192,062.0000 | May 15, 2026 |
| December 2024 | 1,253,484.0000 | -226,258.0000 | 312,006.0000 | 4,623,704.0000 | 4,999,247.0000 | May 15, 2026 |
| December 2023 | 882,533.0000 | 751,609.0000 | 359,724.0000 | — | — | May 15, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $1.25M | December 2025 | May 15, 2026 | 20-F |
| Previous period revenueRevenues | $1.25M | December 2024 | May 15, 2026 | 20-F |
| Net incomeNetIncomeLoss | -$154.82K | December 2025 | May 15, 2026 | 20-F |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$35.85K | December 2025 | May 15, 2026 | 20-F |
| Total assetsAssets | $4.66M | December 2025 | May 15, 2026 | 20-F |
| Total liabilitiesLiabilities | $5.19M | December 2025 | May 15, 2026 | 20-F |